RxSight, Inc. Debt Instrument, Interest Rate During Period
RxSight, Inc. (RXST) reported Debt Instrument, Interest Rate During Period of 15.48% for the 3-month period ending 2023-06-30, per its 10-Q filed 2023-08-07.
Discontinued › Notes › Debt › Debt Instruments
us-gaap:DebtInstrumentInterestRateDuringPeriod · last filed 2023-08-07
- RxSight, Inc. debt instrument, interest rate during period for the quarter ending 2023-06-30 was 15.48%, a 34.61% increase year-over-year.
- RxSight, Inc. debt instrument, interest rate during period for the quarter ending 2023-03-31 was 15.13%, a 41.14% increase year-over-year.
- RxSight, Inc. debt instrument, interest rate during period for the quarter ending 2022-09-30 was 12.66%, a 18.43% increase year-over-year.
- RxSight, Inc. debt instrument, interest rate during period for the quarter ending 2022-06-30 was 11.50%, a 5.50% increase year-over-year.
- RxSight, Inc. debt instrument, interest rate during period for fiscal 2022 was 12.19%, a 11.83% increase from fiscal 2021.
- RxSight, Inc. debt instrument, interest rate during period for fiscal 2021 was 10.90%.
| Period end | Debt Instrument, Interest Rate During Period 3 month | Debt Instrument, Interest Rate During Period 6 month | Debt Instrument, Interest Rate During Period 9 month | Debt Instrument, Interest Rate During Period 12 month |
|---|---|---|---|---|
| 2023-06-30 | 15.48% 10-Q · filed 2023-08-07 | 15.25% 10-Q · filed 2023-08-07 | ||
| 2023-03-31 | 15.13% 10-Q · filed 2023-05-09 | |||
| 2022-12-31 | 12.19% 10-K · filed 2023-03-06 | |||
| 2022-09-30 | 12.66% 10-Q · filed 2022-11-07 | 11.63% 10-Q · filed 2022-11-07 | ||
| 2022-06-30 | 11.50% 10-Q · filed 2023-08-07 | 11.05% 10-Q · filed 2023-08-07 | ||
| 2022-03-31 | 10.72% 10-Q · filed 2023-05-09 | |||
| 2021-12-31 | 10.90% 10-K · filed 2023-03-06 | |||
| 2021-09-30 | 10.69% 10-Q · filed 2022-11-07 | 10.97% 10-Q · filed 2022-11-07 | ||
| 2021-06-30 | 10.90% 10-Q · filed 2022-08-08 | 11.09% 10-Q · filed 2022-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Innovative Eyewear Inc (LUCY) | United States | $0.008B | |
| STAAR SURGICAL CO (STAA) | United States | $0.957B | 362.70 |
| National Vision Holdings, Inc. (EYE) | United States | $1.297B | |
| Warby Parker Inc. (WRBY) | United States | $2.970B | |
| Bausch & Lomb Corp (BLCO) | Canada | $6.008B | -34.58 |
| COOPER COMPANIES, INC. (COO) | United States | $10.533B | 24.09 |